Literature DB >> 29762856

Vitamin D: a steroid hormone with progesterone-like activity.

G Monastra1, S De Grazia, L De Luca, S Vittorio, V Unfer.   

Abstract

OBJECTIVE: This review is aimed at demonstrating the progesterone-like activity exerted by the active form of vitamin D, or calcitriol (1,25(OH)2D). To achieve this outcome, we compared the effects in vivo and in vitro exerted by progesterone and vitamin D, with a special focus on the female reproductive system and pregnancy.
MATERIALS AND METHODS: This is a literature review of the most important articles published in English on vitamin D as a hormone, mainly found by MEDLINE. Furthermore, a section of our review contains some unpublished data, concerning the analysis in silico of the similarities between the steric structure of progesterone and calcitriol, based on the availability of the experimental structures of progesterone and vitamin D3 receptors in complex with their physiological ligands in the RCSB Protein Data Bank.
RESULTS: Vitamin D was shown to exert many physiological activities during the very early stages of gestation in perfect synchrony with progesterone. Both the molecules mutually help and reinforce the activity exerted by each one. A little bit later than progesterone is released, vitamin D secretion rises, but only if pregnancy occurs. Calcitriol contributes to prepare the endometrium to be receptive. Moreover, it supports the implantation process and the course of pregnancy through different but similar pathways to those used by progesterone, giving rise to a significant synergy of action. It is increasingly evident that vitamin D gives an essential support from the luteal phase onwards.
CONCLUSIONS: Based on the evidence displayed in this review we may define appropriately vitamin D as a steroid hormone with progesterone-like activity.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29762856     DOI: 10.26355/eurrev_201804_14845

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  5 in total

1.  Calm the raging hormone - A new therapeutic strategy involving progesterone-signaling for hemorrhagic CCMs.

Authors:  Jun Zhang; Johnathan S Abou-Fadel
Journal:  Vessel Plus       Date:  2021-07-05

Review 2.  Calcifediol (25OHD) Deficiency and Its Treatment in Women's Health and Fertility.

Authors:  Ana Arnanz; Juan A Garcia-Velasco; José Luis Neyro
Journal:  Nutrients       Date:  2022-04-27       Impact factor: 6.706

Review 3.  Natural Molecules in the Management of Polycystic Ovary Syndrome (PCOS): An Analytical Review.

Authors:  Matteo Iervolino; Elisa Lepore; Gianpiero Forte; Antonio Simone Laganà; Giovanni Buzzaccarini; Vittorio Unfer
Journal:  Nutrients       Date:  2021-05-15       Impact factor: 5.717

4.  Association of 25-hydroxyvitamin D with HDL-cholesterol and other cardiovascular risk biomarkers in subjects with non-cardiac chest pain.

Authors:  Mohammad J Alkhatatbeh; Noor A Amara; Khalid K Abdul-Razzak
Journal:  Lipids Health Dis       Date:  2019-01-26       Impact factor: 3.876

5.  Characterization of VDR and CYP27B1 expression in the endometrium during the menstrual cycle before embryo transfer: implications for endometrial receptivity.

Authors:  Jing Guo; Shan Liu; Peng Wang; Haiying Ren; Yuan Li
Journal:  Reprod Biol Endocrinol       Date:  2020-03-17       Impact factor: 5.211

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.